KeyMed Biosciences Inc
HKEX:2162
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
V
|
Visteon Corp
F:VS51
|
US |
|
Nitori Holdings Co Ltd
TSE:9843
|
JP |
|
C
|
China Overseas Land & Investment Ltd
OTC:CAOVY
|
HK |
|
D
|
Danaher Corp
F:DAP
|
US |
|
L
|
Linde PLC
XETRA:LIN
|
UK |
|
B
|
Bank Mandiri (Persero) Tbk PT
XMUN:PQ9
|
ID |
|
Ajinomoto Co Inc
F:AJI
|
JP |
|
W
|
Wabash National Corp
SWB:WA9
|
US |
|
P
|
Prysmian SpA
SWB:AEU
|
IT |
|
S
|
Snam SpA
F:SNM
|
IT |
|
Marathon Petroleum Corp
NYSE:MPC
|
US |
Wall St Price Targets
Price Targets Summary
KeyMed Biosciences Inc
According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 99.71 HKD with a low forecast of 78.78 HKD and a high forecast of 124.82 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KeyMed Biosciences Inc's stock price target?
Price Target
99.71
HKD
According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 99.71 HKD with a low forecast of 78.78 HKD and a high forecast of 124.82 HKD.
What is the Revenue forecast for KeyMed Biosciences Inc?
Projected CAGR
31%
The compound annual growth rate for Revenue over the next 7 years is 31%.
What is the Gross Profit forecast for KeyMed Biosciences Inc?
Projected CAGR
46%
The compound annual growth rate for Gross Profit over the next 3 years is 46%.
